Jan 11, 2023 07:02 PM

BUSINESS

Vaccine-Maker CanSino Bio Plans Swiss Listing

What’s new: Vaccine-maker CanSino Biologics Inc. (688185.SH/6185.HK) is planning to issue global depositary receipts (GDRs) and float the securities on the SIX Swiss exchange, according to a Tuesday exchange filing.

Through the listing, the Chinese company hopes to tap new international financing channels, while improving its international brand to help with its overseas business development.

You've accessed an article available only to subscribers

Subscribe today for just $.99.

VIEW OPTIONS

Share this article

Open WeChat and scan the QR code

GALLERY

: Gallery: Asia New Vision Forum Kicks Off in Singapore

NEWSLETTERS

Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription

PODCAST

Caixin Deep Dive: Former Securities Regulator Yi Huiman’s Corruption Probe

00:00

00:00/00:00

MOST POPULAR

1: Exclusive: China to Create Department to Tackle Trillions in Local Government Debt

2: China Revises Maritime Law, Paving Way for Retaliation Against U.S. Fee Hikes

3: Tianan Property Insurance Defaults on $730 Million Bond in First for China’s Insurance Sector

4: Exclusive: Alleged Chinese Mastermind Behind Massive Bitcoin Money Laundering Stands Trial in U.K.

5: Beijing Warns S&P Global’s China Unit Amid Push to Curb Inflated Credit Ratings

SPONSORED

OR